GlassScriptPhysician profile
Anthony A Rieder
NPI 1710989090
$4,719.80
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $387 · 2021: $924 · 2022: $960 · 2023: $1,568 · 2024: $364 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852 · Travel and Lodging: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.05 |
| Travel and Lodging | $344.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,685.41 | 2019-2025 | |
| Mindray Ds USA, INC. | $967.26 | 2021-2025 | Te X, Te7 Max |
| Inspire Medical Systems, INC. | $772.47 | 2021-2024 | Inspire |
| Acclarent, INC | $668.28 | 2020-2023 | Acclarent Navwire, Trudi Nav Cable, Trudi Nav Suction |
| Intersect Ent, INC. | $260.76 | 2019-2020 | |
| Stryker Corporation | $107.84 | 2019 | |
| Grt US Holding, INC. | $101.45 | 2022 | |
| Spirair, INC. | $77.08 | 2024 | Septalign |
| Nevro Corp. | $31.94 | 2021 | |
| Glaxosmithkline, LLC. | $28.94 | 2024 | Nucala |
| Integra Lifesciences Corporation | $18.37 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rieder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.